Corcept Therapeutics to Announce First Quarter Financial Results and Corporate Update and Host Conference Call
April 30 2014 - 4:30PM
Marketwired
Corcept Therapeutics to Announce First Quarter Financial Results
and Corporate Update and Host Conference Call
MENLO PARK, CA--(Marketwired - Apr 30, 2014) - Corcept
Therapeutics Incorporated (NASDAQ: CORT) today announced it will
report first quarter financial results and provide a corporate
update on May 7, 2014. The Company will also host a conference call
that day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time).
Conference Call Information
To participate, dial 1-888-771-4371 from the United States or
+1-847-585-4405 internationally approximately 10 minutes before the
start of the call. The passcode is 37151424.
A replay will be available through May 21, 2014 at
1-888-843-7419 from the United States and +1-630-652-3042
internationally. The passcode is 37151424.
About Corcept Therapeutics Incorporated
Corcept is a pharmaceutical company engaged in the discovery,
development and commercialization of drugs for the treatment of
severe metabolic, psychiatric and oncologic disorders. Korlym®
(mifepristone) 300 mg Tablets, a first generation GR antagonist, is
the company's first FDA-approved medication for use in the
treatment of patients with Cushing's syndrome. Corcept has a phase
3 trial underway for mifepristone for treatment of psychotic
depression and a phase 1 trial for mifepristone in combination with
chemotherapy for the treatment of relapsed, metastatic
triple-negative breast cancer. It also has a portfolio of selective
GR antagonists that block the effects of cortisol without blocking
the effects of progesterone. The company owns extensive
intellectual property covering the use of GR antagonists, including
mifepristone, in the treatment of a wide variety of disorders. It
also holds composition of matter patents for its selective GR
antagonists. For more information about Corcept please visit:
www.corcept.com.
CONTACT: Charles Robb Chief Financial Officer Corcept
Therapeutics 650-688-8783 Email Contact www.corcept.com
Corcept Therapeutics (NASDAQ:CORT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Corcept Therapeutics (NASDAQ:CORT)
Historical Stock Chart
From Apr 2023 to Apr 2024